[1]
Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K, Bowen T, Balle Boysen H, Farkas H, Grumach AS, Hide M, Katelaris C, Lockey R, Longhurst H, Lumry WR, Martinez-Saguer I, Moldovan D, Nast A, Pawankar R, Potter P, Riedl M, Ritchie B, Rosenwasser L, Sánchez-Borges M, Zhi Y, Zuraw B, Craig T. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy. 2018 Aug:73(8):1575-1596. doi: 10.1111/all.13384. Epub 2018 Mar 12
[PubMed PMID: 29318628]
[2]
Bernstein JA, Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. International journal of emergency medicine. 2012 Nov 6:5(1):39. doi: 10.1186/1865-1380-5-39. Epub 2012 Nov 6
[PubMed PMID: 23131076]
[3]
Kelly M, Donnelly JP, McAnnally JR, Wang HE. National estimates of emergency department visits for angioedema and allergic reactions in the United States. Allergy and asthma proceedings. 2013 Mar-Apr:34(2):150-4. doi: 10.2500/aap.2013.34.3640. Epub
[PubMed PMID: 23484890]
[4]
Bertazzoni G, Spina MT, Scarpellini MG, Buccelletti F, De Simone M, Gregori M, Valeriano V, Pugliese FR, Ruggieri MP, Magnanti M, Susi B, Minetola L, Zulli L, D'Ambrogio F. Drug-induced angioedema: experience of Italian emergency departments. Internal and emergency medicine. 2014 Jun:9(4):455-62. doi: 10.1007/s11739-013-1007-x. Epub 2013 Nov 9
[PubMed PMID: 24214335]
[5]
Felder S, Curtis RM, Ball I, Borici-Mazi R. Prognostic factors in outcome of angioedema in the emergency department. Allergy and asthma proceedings. 2014 Sep-Oct:35(5):362-70. doi: 10.2500/aap.2014.35.3787. Epub
[PubMed PMID: 25295803]
[6]
Jolles S, Williams P, Carne E, Mian H, Huissoon A, Wong G, Hackett S, Lortan J, Platts V, Longhurst H, Grigoriadou S, Dempster J, Deacock S, Khan S, Darroch J, Simon C, Thomas M, Pavaladurai V, Alachkar H, Herwadkar A, Abinun M, Arkwright P, Tarzi M, Helbert M, Bangs C, Pastacaldi C, Phillips C, Bennett H, El-Shanawany T. A UK national audit of hereditary and acquired angioedema. Clinical and experimental immunology. 2014 Jan:175(1):59-67. doi: 10.1111/cei.12159. Epub
[PubMed PMID: 23786259]
[7]
Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). The Journal of allergy and clinical immunology. 2007 Jun:119(6):1497-503
[PubMed PMID: 17418383]
[8]
Morgan BP. Hereditary angioedema--therapies old and new. The New England journal of medicine. 2010 Aug 5:363(6):581-3. doi: 10.1056/NEJMe1006450. Epub
[PubMed PMID: 20818894]
[9]
Bracho FA. Hereditary angioedema. Current opinion in hematology. 2005 Nov:12(6):493-8
[PubMed PMID: 16217168]
Level 3 (low-level) evidence
[10]
Betschel S, Badiou J, Binkley K, Borici-Mazi R, Hébert J, Kanani A, Keith P, Lacuesta G, Waserman S, Yang B, Aygören-Pürsün E, Bernstein J, Bork K, Caballero T, Cicardi M, Craig T, Farkas H, Grumach A, Katelaris C, Longhurst H, Riedl M, Zuraw B, Berger M, Boursiquot JN, Boysen H, Castaldo A, Chapdelaine H, Connors L, Fu L, Goodyear D, Haynes A, Kamra P, Kim H, Lang-Robertson K, Leith E, McCusker C, Moote B, O'Keefe A, Othman I, Poon MC, Ritchie B, St-Pierre C, Stark D, Tsai E. The International/Canadian Hereditary Angioedema Guideline. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. 2019:15():72. doi: 10.1186/s13223-019-0376-8. Epub 2019 Nov 25
[PubMed PMID: 31788005]
[11]
Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA Jr, Collins SP, Craig TJ, Lumry WR, Nowak R, Pines JM, Raja AS, Riedl M, Ward MJ, Zuraw BL, Diercks D, Hiestand B, Campbell RL, Schneider S, Sinert R, American College of Allergy, Asthma & Immunology (ACAAI), Society for Academic Emergency Medicine (SAEM). A consensus parameter for the evaluation and management of angioedema in the emergency department. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2014 Apr:21(4):469-84. doi: 10.1111/acem.12341. Epub
[PubMed PMID: 24730413]
Level 3 (low-level) evidence
[12]
Katelaris CH. Acute Management of Hereditary Angioedema Attacks. Immunology and allergy clinics of North America. 2017 Aug:37(3):541-556. doi: 10.1016/j.iac.2017.04.002. Epub 2017 May 23
[PubMed PMID: 28687108]
[13]
Hide M, Fukunaga A, Maehara J, Eto K, Hao J, Vardi M, Nomoto Y. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study. Allergology international : official journal of the Japanese Society of Allergology. 2020 Apr:69(2):268-273. doi: 10.1016/j.alit.2019.08.012. Epub 2019 Oct 28
[PubMed PMID: 31672405]
[14]
MacBeth LS, Volcheck GW, Sprung J, Weingarten TN. Perioperative course in patients with hereditary or acquired angioedema. Journal of clinical anesthesia. 2016 Nov:34():385-91. doi: 10.1016/j.jclinane.2016.05.010. Epub 2016 Jun 5
[PubMed PMID: 27687418]
[15]
Bekos C, Perkmann T, Krauth M, Raderer M, Lechner K, Jaeger U. Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment. Leukemia & lymphoma. 2016 Sep:57(9):2033-6. doi: 10.3109/10428194.2015.1131273. Epub 2016 Jan 21
[PubMed PMID: 26795750]
[16]
Gobert D, Paule R, Ponard D, Levy P, Frémeaux-Bacchi V, Bouillet L, Boccon-Gibod I, Drouet C, Gayet S, Launay D, Martin L, Mekinian A, Leblond V, Fain O. A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients. Medicine. 2016 Aug:95(33):e4363. doi: 10.1097/MD.0000000000004363. Epub
[PubMed PMID: 27537564]
[17]
Fox J, Vegh AB, Martinez-Saguer I, Wuillemin WA, Edelman J, Williams-Herman D, Rojavin M, Rosenberg T. Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema. Allergy and asthma proceedings. 2017 May 1:38(3):216-221. doi: 10.2500/aap.2017.38.4038. Epub
[PubMed PMID: 28441992]
[18]
Farkas H, Kőhalmi KV, Veszeli N, Tóth F, Varga L. First report of icatibant treatment in a pregnant patient with hereditary angioedema. The journal of obstetrics and gynaecology research. 2016 Aug:42(8):1026-8. doi: 10.1111/jog.13003. Epub 2016 Apr 19
[PubMed PMID: 27093898]
[19]
Lumry W, Soteres D, Gower R, Jacobson KW, Li HH, Chen H, Schranz J. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2015 Nov:26(7):674-80. doi: 10.1111/pai.12444. Epub 2015 Aug 11
[PubMed PMID: 26171584]
[20]
Strassen U, Bas M, Hoffmann TK, Knopf A, Greve J. Treatment of angiotensin receptor blocker-induced angioedema: A case series. The Laryngoscope. 2015 Jul:125(7):1619-23. doi: 10.1002/lary.25163. Epub 2015 Feb 3
[PubMed PMID: 25646708]
Level 2 (mid-level) evidence
[21]
Craig TJ, Schneider LC, MacGinnitie AJ. Plasma-derived C1-INH for managing hereditary angioedema in pediatric patients: A systematic review. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2015 Sep:26(6):537-44. doi: 10.1111/pai.12425. Epub
[PubMed PMID: 26111105]
Level 1 (high-level) evidence
[22]
Loudin M, Modiano N, Sallay S. Rapid Improvement of Pancreatitis Secondary to Hereditary Angioedema with C1 Inhibitor Administration. The American journal of medicine. 2016 Jul:129(7):e75-6. doi: 10.1016/j.amjmed.2016.02.045. Epub 2016 Apr 4
[PubMed PMID: 27056293]
[23]
Scott SI, Andersen MF, Aagaard L, Buchwald CV, Rasmussen ER. Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema - An Overlooked Adverse Drug Reaction? Current diabetes reviews. 2018:14(4):327-333. doi: 10.2174/1573399813666170214113856. Epub
[PubMed PMID: 28201967]
[24]
Peveling-Oberhag A, Reimann H, Weyer V, Goloborodko E, Staubach P. High-Concentration Liquid Prednisolone Formula: Filling a Therapeutic Niche in Severe Acute Attacks of Urticaria and Angioedema. Skin pharmacology and physiology. 2016:29(1):9-12. doi: 10.1159/000439032. Epub 2015 Oct 15
[PubMed PMID: 26465879]
[25]
Tourangeau LM, Castaldo AJ, Davis DK, Koziol J, Christiansen SC, Zuraw BL. Safety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy. International archives of allergy and immunology. 2012:157(4):417-24. doi: 10.1159/000329635. Epub 2011 Nov 25
[PubMed PMID: 22123229]